£108.01

Humana Antibody-Drug Conjugates and Immunotoxins Book

Price data last checked 34 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

This is the most expensive it has ever been. Walk away.

£108 today · previous high £108 · all-time low £108

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 57 days · 57 data points (no recent data)

Historical
Generating forecast…
£108.01 £107.98 £107.98 £107.99 £108.00 £108.01 £108.01 09 June 2026 23 June 2026 07 July 2026 21 July 2026 04 August 2026

Price Distribution

Price distribution over 57 days • 1 price levels

Days at Price
57 days 0 14 29 43 57 £108 Days at Price

Price Analysis

Most common price: £108 (57 days, 100.0%)

Price range: £108 - £108

Price levels: 1 different prices over 57 days

Description

Explore the evolution of targeted cancer treatments with Antibody-Drug Conjugates and Immunotoxins: From Pre-Clinical Development to Therapeutic Applications. This specialized volume brings together leading research on antibody-drug conjugates (ADCs) and immunotoxins (ITs), providing a comprehensive look at the transition from early concepts to modern medical realities. Since Paul Ehrlich first proposed the idea of magic bullets, the field has transformed through the approval of monoclonal antibody therapies. This book tracks that progress, examining every stage of the process from clinical development to the latest technological advancements in the field. It is an essential resource for those studying how monoclonal antibodies are linked to potent cytotoxic agents to create highly targeted therapies. Whether you are researching cancer drug discovery or studying the development of targeted therapeutic applications, this text provides a deep look into the science of delivering medicine directly to diseased cells. It covers the technical aspects of conjugation and the clinical pathways required to bring these advanced therapies to patients.

Key Features

Covers the full spectrum of ADC and IT development from pre-clinical stages to therapeutic applications.

Provides detailed research on the use of monoclonal antibodies conjugated with potent cytotoxic agents.

Examines the latest technologies driving advancements in targeted cancer drug discovery.

Traces the historical progression of the magic bullet concept through to modern monoclonal antibody therapies.

Offers insights into clinical development processes for antibody-drug conjugates and immunotoxins.

Product Specifications

Brand
Humana
Format
paperback
Domain
Amazon UK
Release Date
28 January 2015
Listed Since
29 January 2015

Barcode

No barcode data available

Similar Products You Might Like

Antibody-Drug Conjugates: The 21st Century Magic Bullets for Cancer: 17 (AAPS Advances in the Pharmaceutical Sciences Series, 17)
98% match

Antibody-Drug Conjugates: The 21st Century Magic Bullets for Cancer: 17 (AAPS Advances in the Pharmaceutical Sciences Series, 17)

Springer

£100.49 12 Aug 2026
Innovations for Next-Generation Antibody-Drug Conjugates (Cancer Drug Discovery and Development)
97% match

Innovations for Next-Generation Antibody-Drug Conjugates (Cancer Drug Discovery and Development)

Humana

£107.98 08 Jul 2026
Antibody-Drug Conjugates: 1045 (Methods in Molecular Biology, 1045)
97% match

Antibody-Drug Conjugates: 1045 (Methods in Molecular Biology, 1045)

Humana

£80.66 06 Jul 2026
A Beginner's Guide to Targeted Cancer Treatments and Cancer Immunotherapy
96% match

A Beginner's Guide to Targeted Cancer Treatments and Cancer Immunotherapy

Wiley

£44.48 11 Jul 2026
Humana Recombinant Antibodies for Cancer Therapy - Volume 207
96% match

Humana Recombinant Antibodies for Cancer Therapy - Volume 207

Humana

£51.33 18 Jul 2026
Tumor Immunology: Methods and Protocols: 1393 (Methods in Molecular Biology, 1393)
96% match

Tumor Immunology: Methods and Protocols: 1393 (Methods in Molecular Biology, 1393)

Humana

£69.36 07 Jul 2026
Antibody-Drug Conjugates: Methods and Protocols: 2078 (Methods in Molecular Biology, 2078)
96% match

Antibody-Drug Conjugates: Methods and Protocols: 2078 (Methods in Molecular Biology, 2078)

Humana

£81.84 08 Jul 2026
Macromolecular Anticancer Therapeutics (Cancer Drug Discovery and Development)
96% match

Macromolecular Anticancer Therapeutics (Cancer Drug Discovery and Development)

Humana

£143.84 20 Aug 2026
Macromolecular Anticancer Therapeutics (Cancer Drug Discovery and Development)
96% match

Macromolecular Anticancer Therapeutics (Cancer Drug Discovery and Development)

Humana

£148.31 10 Jul 2026
Cancer Biotherapy: An Introductory Guide
96% match

Cancer Biotherapy: An Introductory Guide

Oxford University Press

£92.24 31 Jul 2026
Current Immunotherapeutic Strategies in Cancer: 214 (Recent Results in Cancer Research, 214)
96% match

Current Immunotherapeutic Strategies in Cancer: 214 (Recent Results in Cancer Research, 214)

Springer

£87.93 14 Jul 2026
Biomarkers for Immunotherapy of Cancer: Methods and Protocols: 2055 (Methods in Molecular Biology, 2055)
96% match

Biomarkers for Immunotherapy of Cancer: Methods and Protocols: 2055 (Methods in Molecular Biology, 2055)

Humana

£156.36 12 Aug 2026
Biomarkers for Immunotherapy of Cancer: Methods and Protocols: 2055 (Methods in Molecular Biology, 2055)
96% match

Biomarkers for Immunotherapy of Cancer: Methods and Protocols: 2055 (Methods in Molecular Biology, 2055)

Humana

£110.83 08 Jul 2026
Springer - Tumor-Induced Immune Suppression Book
96% match

Springer - Tumor-Induced Immune Suppression Book

Springer

£129.22 26 Jul 2026
Immunotherapy in Translational Cancer Research (Translational Oncology)
96% match

Immunotherapy in Translational Cancer Research (Translational Oncology)

Wiley

£130.00 22 Aug 2026
Springer - Novel Immunotherapeutic Approaches to Cancer Treatment
96% match

Springer - Novel Immunotherapeutic Approaches to Cancer Treatment

Springer

£108.91 16 Jul 2026
Springer - Novel Immunotherapeutic Approaches to Cancer Treatment
96% match

Springer - Novel Immunotherapeutic Approaches to Cancer Treatment

Springer

£113.97 15 Jul 2026
Antibodies for Treating Cancer: Basics, Development, and Applications
96% match

Antibodies for Treating Cancer: Basics, Development, and Applications

Springer

£50.91 01 Aug 2026
Immune Mediators in Cancer: Methods and Protocols: 2108 (Methods in Molecular Biology)
96% match

Immune Mediators in Cancer: Methods and Protocols: 2108 (Methods in Molecular Biology)

Humana

£89.34 03 Jul 2026
Cytotoxic Payloads for Antibody–Drug Conjugates: Volume 71 (Drug Discovery Series)
96% match

Cytotoxic Payloads for Antibody–Drug Conjugates: Volume 71 (Drug Discovery Series)

Royal Society of Chemistry

£132.53 24 Aug 2026
Cancer Immunology: Innovative Approaches to Therapy: 27 (Cancer Treatment and Research)
96% match

Cancer Immunology: Innovative Approaches to Therapy: 27 (Cancer Treatment and Research)

Springer

£165.42 03 Jul 2026
Development of Antibody-Based Therapeutics: Translational Considerations & Challenges
96% match

Development of Antibody-Based Therapeutics: Translational Considerations & Challenges

Adis

£80.43 19 Aug 2026
Cancer Therapy: Monoclonal Antibodies, Lymphokines New Developments in Surgical Oncology and Chemo- and Hormonal Therapy
96% match

Cancer Therapy: Monoclonal Antibodies, Lymphokines New Developments in Surgical Oncology and Chemo- and Hormonal Therapy

Springer

£78.82 04 Jul 2026
Immunoconjugate Therapy of Hematologic Malignancies: 68 (Cancer Treatment and Research, 68)
96% match

Immunoconjugate Therapy of Hematologic Malignancies: 68 (Cancer Treatment and Research, 68)

Springer

£179.99 13 Jul 2026